Form 4: Cognex Director Converts RSUs to Common Stock
Insider Ownership Change
Cognex Director Dianne M. Parrotte acquired 8,324 shares of common stock through the conversion of restricted stock units.
Summary
- Dianne M. Parrotte, a Director at Cognex Corp (CGNX), reported a change in beneficial ownership.
- On February 18, 2026, Parrotte acquired 8,324 shares of Cognex common stock.
- This acquisition resulted from the conversion of 8,324 restricted stock units (RSUs) at an exercise price of $0.0.
- Following this transaction, Parrotte directly beneficially owns 30,518 shares of Cognex common stock.
- Parrotte also holds various non-qualified stock options and additional restricted stock units.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a routine, slightly positive event, reflecting a director's increased direct stake in the company through a standard compensation mechanism, which aligns their interests with shareholders.
Positives
- Director Parrotte increased her direct ownership of common stock by 8,324 shares, indicating continued alignment with shareholder interests.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that routine insider transactions like RSU conversions are common and generally reflect compensation plans rather than specific market timing decisions. For Cognex, a leader in machine vision, such equity-based compensation is standard practice to align director interests with long-term company performance.
Comparison to Industry Standards
- The RSU conversion and subsequent increase in direct share ownership by a director is a standard practice in corporate compensation structures across various industries, including technology and industrial automation. It aligns director incentives with shareholder value creation.
Stakeholder Impact
- Shareholders: Increased direct ownership by a director can be seen as a positive signal of confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 05/02/2019 | Grant date for 7,500 Non-Qualified Stock Options with an exercise price of $45.06. |
| 02/19/2020 | Grant date for 18,100 Non-Qualified Stock Options with an exercise price of $51.49. |
| 02/18/2021 | Grant date for 18,400 Non-Qualified Stock Options with an exercise price of $50.94. |
| 02/21/2024 | Grant date for 2,913 Restricted Stock Units. |
| 02/18/2025 | Vesting date for 8,324 Restricted Stock Units. |
| 02/18/2026 | Transaction date for the conversion of 8,324 Restricted Stock Units into common stock. |
| 02/19/2026 | Signature date of the reporting person. |
| 02/21/2026 | Expiration date for 2,913 Restricted Stock Units. |
| 05/02/2028 | Expiration date for 7,500 Non-Qualified Stock Options. |
| 02/19/2029 | Expiration date for 18,100 Non-Qualified Stock Options. |
| 02/18/2030 | Expiration date for 18,400 Non-Qualified Stock Options. |
Recommendation
holdThis Form 4 filing details a routine conversion of restricted stock units by a director, which is a standard compensation event and does not provide new fundamental information to warrant a change in investment thesis. It reinforces insider alignment but offers no new catalysts for a 'buy' or 'sell' recommendation.
Keywords
Cognex Corp, CGNX, Dianne M. Parrotte, Director, Insider Transaction, Form 4, Restricted Stock Units, Common Stock, Stock Options, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.